Next Article in Journal
IKZF1 Variants Predicted Poor Outcomes in Acute Myeloid Leukemia Patients with CEBPA bZIP In-Frame Mutations
Previous Article in Journal
The Role of Prophylactic HIPEC in High-Risk Gastric Cancer Patients: Where Do We Stand?
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Jeong et al. WBP5 Expression Influences Prognosis and Treatment Response in Head and Neck Squamous Cell Carcinoma. Cancers 2025, 17, 587

1
Department of Otorhinolaryngology–Head and Neck Surgery, Konyang University College of Medicine, Daejeon 35365, Republic of Korea
2
Department of Otorhinolaryngology–Head and Neck Surgery, Korea University College of Medicine, Seoul 02841, Republic of Korea
3
BK21 FOUR KNU Creative BioResearch Group, Department of Biology, College of Natural Sciences, Kyungpook National University, Daegu 41566, Republic of Korea
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Cancers 2025, 17(15), 2493; https://doi.org/10.3390/cancers17152493
Submission received: 14 July 2025 / Accepted: 14 July 2025 / Published: 29 July 2025

Error in Figure

In the original publication [1], there was a mistake in Figure 6A as published. The gene label “WDR54” was incorrectly used instead of “WBP5”.
The correct figure is provided below:
Figure 6. Correlation of WBP5 and EGFR expression across different cancer types and datasets. (A) Heatmaps of WBP5 and EGFR expression across HNSCC, with darker blue indicating higher expression levels. (B) Scatter plot showing the correlation between WBP5 and EGFR expression (log2 TPM) across samples, with a positive correlation (R = 0.26, p = 5.6 × 1010). (C) Scatter plots showing the correlation between WBP5 and EGFR expression in specific datasets (GSE33232 and GSE178537). Both datasets demonstrate a positive correlation between WBP5 and EGFR expression, with GSE33232 (R = 0.4231, p = 0.004) and GSE178537 (R = 0.5266, p = 0.021) (* p < 0.05 and ** p < 0.01).
Figure 6. Correlation of WBP5 and EGFR expression across different cancer types and datasets. (A) Heatmaps of WBP5 and EGFR expression across HNSCC, with darker blue indicating higher expression levels. (B) Scatter plot showing the correlation between WBP5 and EGFR expression (log2 TPM) across samples, with a positive correlation (R = 0.26, p = 5.6 × 1010). (C) Scatter plots showing the correlation between WBP5 and EGFR expression in specific datasets (GSE33232 and GSE178537). Both datasets demonstrate a positive correlation between WBP5 and EGFR expression, with GSE33232 (R = 0.4231, p = 0.004) and GSE178537 (R = 0.5266, p = 0.021) (* p < 0.05 and ** p < 0.01).
Cancers 17 02493 g006

Text Correction

There was an error in the original publication [1]. The protein name was incorrectly written as “WW domain C-binding protein 5 (WBP5)”, instead of “WW domain protein 5 (WBP5)” in the Introduction, paragraph 2.
The correct text is provided below:
“WW domain protein 5 (WBP5), alternatively referred to as Transcriptional Elongation Factor A-like 9 (TCEAL9), engages with diverse signaling pathways and associated with WW domains [3]”.
A correction has been made to Materials and Methods, 4.8. Cell Culturing and Viability Assessment, where “WDR54-knockdown FaDu cells” was incorrectly written instead of “WBP5-knockdown FaDu cells”.
The correct text is provided below:
“Assays were conducted using WBP5-knockdown FaDu cells. For the cell viability experiments, 3 × 103 cells/well were seeded into 96-well plates, while 1 × 103 cells/well were plated for proliferation analysis.”
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Jeong, E.-j.; Kim, E.; Jung, K.-Y.; Baek, S.-K.; Kim, Y.S. WBP5 Expression Influences Prognosis and Treatment Response in Head and Neck Squamous Cell Carcinoma. Cancers 2025, 17, 587. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Jeong, E.-j.; Kim, E.; Jung, K.-Y.; Baek, S.-K.; Kim, Y.S. Correction: Jeong et al. WBP5 Expression Influences Prognosis and Treatment Response in Head and Neck Squamous Cell Carcinoma. Cancers 2025, 17, 587. Cancers 2025, 17, 2493. https://doi.org/10.3390/cancers17152493

AMA Style

Jeong E-j, Kim E, Jung K-Y, Baek S-K, Kim YS. Correction: Jeong et al. WBP5 Expression Influences Prognosis and Treatment Response in Head and Neck Squamous Cell Carcinoma. Cancers 2025, 17, 587. Cancers. 2025; 17(15):2493. https://doi.org/10.3390/cancers17152493

Chicago/Turabian Style

Jeong, Eun-jeong, Eunjeong Kim, Kwang-Yoon Jung, Seung-Kuk Baek, and Yeon Soo Kim. 2025. "Correction: Jeong et al. WBP5 Expression Influences Prognosis and Treatment Response in Head and Neck Squamous Cell Carcinoma. Cancers 2025, 17, 587" Cancers 17, no. 15: 2493. https://doi.org/10.3390/cancers17152493

APA Style

Jeong, E.-j., Kim, E., Jung, K.-Y., Baek, S.-K., & Kim, Y. S. (2025). Correction: Jeong et al. WBP5 Expression Influences Prognosis and Treatment Response in Head and Neck Squamous Cell Carcinoma. Cancers 2025, 17, 587. Cancers, 17(15), 2493. https://doi.org/10.3390/cancers17152493

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop